What is ImmuneBridge worth?
$25.0Mlast known valuation
ImmuneBridge last raised $5.6M in its Early Stage VC (Mar 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for ImmuneBridge
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2025 | Early Stage VC | $5.6M | ▮ | ▮ |
| Dec 2022 | Early Stage VC | $10.2M | ▮ | ▮ |
How ImmuneBridge's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ImmuneBridge, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is ImmuneBridge worth?
- ImmuneBridge's last known valuation is $25.0M.
- How much has ImmuneBridge raised?
- ImmuneBridge has raised $19.7M in total funding across 2 recorded rounds.
- When did ImmuneBridge last raise?
- ImmuneBridge last raised in Mar 2025 (Early Stage VC), raising $5.6M.